Ceritinib for untreated ALK-positive non-small-cell lung cancer

Equality Impact Assessment (Guidance development) (PDF 221 KB)

Final appraisal determination

Final appraisal determination document (PDF 312 KB)

Committee papers (PDF 18.7 MB)

Public committee slides Clinical slides (PDF 533 KB)

Public committee slides Cost slides (PDF 327 KB)

Final scope (PDF 252 KB)

Draft scope and provisional matrix comments table (post-referral) (PDF 265 KB)

Equality impact assessment (Scoping) (PDF 173 KB)

Final matrix (PDF 337 KB)